30 June 2021 in Medicine Today and Tomorrow
The relationship between menstrual disorders and obesity of different genesis in adolescent girls has been analyzed. Based on clinical and ultrasound parallels in girls with menstrual disorders on the background of obesity of various genesis, the available data on the pathogenesis of reproductive health disorders in this pathology have been expanded, and the need to improve the algorithm of diagnostic and treatment and prevention measures has been scientifically substantiated. The most informative prognostic criteria for the occurrence of menstrual disorders in obese adolescent girls have been identified, on the basis of which it is possible to form risk groups in which primary prevention is required. According to the World Health Organization, the prevalence of obesity among women of childbearing age ranges from 1.8 to 25.3% in different countries. Body weight plays an important role in the formation of menstrual function. It is known that adipose tissue is involved in the regulation of the menstrual cycle, because it also synthesizes female sex hormones. Excess adipose tissue accumulates steroids and active estrogens. This leads to a change in the production of a number of hormones that disrupt the coordination of the neuroendocrine system. We can say that excess adipose tissue becomes an additional endocrine gland. Keywords: adolescent girls, overweight, menstrual disorders.
28 May 2026 in Clinical anatomy and operative surgery
The process of forming the reproductive potential of an individual is multifaceted and begins with the stage of antenatal development. The most critical phase is the puberty period, since it is accompanied by active somatic and psychological restructuring, as well as the completion of the formation of the reproductive system. Since adolescence determines future behavioral attitudes in this area, the health protection of the younger generation becomes a strategic task that guarantees the social and psychophysical well-being of the adult population. Despite the availability of modern diagnostic and treatment methods in Ukraine, the reproductive health of the female population remains unsatisfactory. This necessitates the improvement of approaches to preserving reproductive potential at the early stages of development. The link between obesity and the menstrual cycle warrants particular attention. Although scientific perspectives on this issue vary, it has been proven that the timing of onset and the regularity of menstruation critically influence reproductive function. Specifically, early menarche is considered a risk factor for increased BMI and impaired fertility, while late onset of menstruation and a prolonged cycle stabilization period have the most destructive impact. In cases of alimentary obesity, the risk of menstrual disorders increases 6.1 times, and the rate of primary infertility nearly doubles. The aforementioned factors create the prerequisites for puberty disorders and menstrual cycle abnormalities. The global prevalence of obesity necessitates its study within the context of reproductive medicine, as adipose tissue, acting as an endocrine organ, is capable of provoking functional disturbances. Timely correction of the menstrual rhythm during adolescence is a strategic measure for infertility prevention. This defines the objective of the study: to enhance the effectiveness of reproductive function recovery and weight loss in adolescent girls through the implementation of an improved therapeutic complex.
6 October 2026 in Zaporozhye Medical Journal
Obesity in adolescent girls is a major medical and social problem because excess body weight at an early age increases the risk of chronic metabolic, cardiovascular, and endocrine disorders, adversely affects reproductive health, and may cause psychosocial consequences. Adolescence is a transitional period characterized by rapid growth, pubertal development, and the onset of menstruation, during which menstrual disorders may emerge. The aim of this study was to analyze the relationship between obesity and menstrual disorders and to substantiate therapeutic strategies aimed at correcting the underlying pathogenetic mechanism. Material and methods. We performed a comprehensive clinical and laboratory examination of 79 girls aged 12−18 years with menstrual dysfunction associated with obesity (main group), and 31 girls of the same age with a regular menstrual cycle (control group). The main group included patients with menstrual dysfunction and delayed menstruation for up to 5 months. Results. In girls with a regular menstrual cycle, the absence of hyperandrogenism and insulin resistance was associated with HOMA-AD values below 3.45. When HOMA-AD was below this threshold, the prognosis for restoration of the menstrual cycle was favorable, and treatment aimed at improving insulin sensitivity was considered effective. At HOMA-AD values of 3.45 or higher, insulin sensitizers should be included in the treatment regimen. The diagnostic accuracy of this classification model was 94.2 %, with sensitivity of 93.3 % and specificity of 94.4 %. Retrospectively, 94 % of patients in the main group had values above the diagnostic threshold, indicating insulin resistance. Conclusions. Primary menstrual dysfunction associated with obesity indicates the need to improve therapeutic and preventive measures aimed at timely correction of reproductive and somatic health disorders. Compared with traditional treatment in patients with primary menstrual dysfunction lasting up to 2 years, the proposed non-hormonal treatment complex increased the frequency of menstrual normalization with BMI reduction after 3 months to 78.0 % versus 90.3 %, and after 1 year to 73.1 % versus 80.0 %. With longer duration of menstrual dysfunction, the frequency of excellent outcomes increased: the proportion of patients with reduced BMI after 3 months was 79.3 % versus 58.9 %, and after 1 year 69.8 % versus 51.4 %.